Assess the Ability of Electrical Cardiometry to Trend Hemodynamic Variables During Dexmedetomidine Sedation
| Status: | Completed |
|---|---|
| Conditions: | Cardiology, Hospital |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Other |
| Healthy: | No |
| Age Range: | Any - 18 |
| Updated: | 1/6/2017 |
| Start Date: | September 2009 |
| End Date: | September 2011 |
A Pilot Study to Assess the Ability of Non-invasive Bio-impedance Cardiac Monitoring to Detect and Trend Hemodynamic Variables During Dexmedetomidine (DEX) Sedation in Children for Radiology Procedures
The aim of the study is to investigate the use of a new FDA-approved non-invasive
bio-impedance cardiac monitor, ICON, to detect hemodynamic effects during sedation in
children undergoing radiology procedures. The purpose of the study is to determine the
ability of the ICON monitor to identify the anticipated and documented hemodynamic changes
in children which occur in response to Dexmedetomidine sedation. The investigators postulate
that if the ICON device can trend hemodynamic changes, if any, during dexmedetomidine (DEX)
sedation in children the investigators can delineate changes in cardiac output, stroke
volume, and systemic vascular resistance associated with observed changes in heart rate and
blood pressure.
bio-impedance cardiac monitor, ICON, to detect hemodynamic effects during sedation in
children undergoing radiology procedures. The purpose of the study is to determine the
ability of the ICON monitor to identify the anticipated and documented hemodynamic changes
in children which occur in response to Dexmedetomidine sedation. The investigators postulate
that if the ICON device can trend hemodynamic changes, if any, during dexmedetomidine (DEX)
sedation in children the investigators can delineate changes in cardiac output, stroke
volume, and systemic vascular resistance associated with observed changes in heart rate and
blood pressure.
Inclusion Criteria:
- All pediatric patients (1 month to 18 years of age)
- Eligible for Radiology Sedation Service for CT scan and Nuclear Medicine
- Scan procedure
Exclusion Criteria:
- Pacemakers and Vagus Nerve Stimulator
- Mitral or Aorta Valve Dysfunction
- Dextrocardia
- Second or Third degree heart block
- Current diagnosis of Cardiac, Pulmonary, Hepatic or Renal Failure
- Current diagnosis of pulmonary masses/tumor/pleural effusions/pneumonia/edema
- Pericardial effusion
- Concomitant use of hypertension medications including ACE inhibitors, beta receptor
and calcium channel blockers.
- Large Implanted Metallic Devices (including orthodontic braces, spine rods, plates
and screws)
- Allergy to device electrodes
We found this trial at
1
site
Click here to add this to my saved trials
